<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006678</article-id><article-id pub-id-type="pmc">PMC11861309</article-id><article-id pub-id-type="doi">10.3390/vaccines13020131</article-id><article-id pub-id-type="publisher-id">vaccines-13-00131</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Vertical and Horizontal Transmission of Neosporosis in Three Consecutive Pregnancies of Naturally Infected Pregnant Cows and the Effect of Vaccination on Abortion Rates</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3810-8418</contrib-id><name><surname>Tirosh-Levy</surname><given-names>Sharon</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing &#x02013; original draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing &#x02013; review &#x00026; editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-vaccines-13-00131" ref-type="aff">1</xref><xref rid="af2-vaccines-13-00131" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Blinder</surname><given-names>Elena</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-vaccines-13-00131" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Yasur-Landau</surname><given-names>Daniel</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-vaccines-13-00131" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3371-2904</contrib-id><name><surname>Lavon</surname><given-names>Yaniv</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data curation/">Data curation</role><xref rid="af3-vaccines-13-00131" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Doekes</surname><given-names>Jacob Joost</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af4-vaccines-13-00131" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5357-0136</contrib-id><name><surname>Mazuz</surname><given-names>Monica L.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing &#x02013; review &#x00026; editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-vaccines-13-00131" ref-type="aff">1</xref><xref rid="c1-vaccines-13-00131" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Matsuyama-Kato</surname><given-names>Ayumi</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Careem</surname><given-names>Faizal</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vaccines-13-00131"><label>1</label>Division of Parasitology, Kimron Veterinary Institute, Beit Dagan 502001, Israel; <email>sharontirosh@gmail.com</email> (S.T.-L.); <email>elenab@moag.gov.il</email> (E.B.); <email>daniely@moag.gov.il</email> (D.Y.-L.)</aff><aff id="af2-vaccines-13-00131"><label>2</label>Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 7610001, Israel</aff><aff id="af3-vaccines-13-00131"><label>3</label>Israel Cattle Breeders Association, Caesarea 3097020, Israel; <email>yaniv@icba.co.il</email></aff><aff id="af4-vaccines-13-00131"><label>4</label>Hachaklait Veterinary Services, Caesarea 3097020, Israel; <email>dukas@hak.org.il</email></aff><author-notes><corresp id="c1-vaccines-13-00131"><label>*</label>Correspondence: <email>monical@moag.gov.il</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>131</elocation-id><history><date date-type="received"><day>19</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>12</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background/Objectives:Neosporosis is a major cause of abortions in cattle worldwide. Primary results showed that the administration of a live attenuated vaccine during the mid-pregnancy stage of naturally infected cows may assist in preventing abortions. In this study, the effect of vaccination was evaluated in five dairy herds, with a follow-up of three consecutive pregnancies and re-vaccination during the subsequent pregnancies of some of the cows. Methods: A total of 1059 heifers were serologically tested during their first pregnancy, and 260 and 21 of them were re-tested during their second and third pregnancies. Vaccination was administered to 193 of 420 cows with antibody titers of 1:800 or higher, and 23 of them were re-vaccinated. Data were collected regarding the outcome of each pregnancy, the number of inseminations required and removal from the herd. Vertical transmission was evaluated in 136 pre-colostral calves born from 29 vaccinated and 107 unvaccinated dams. Results: The total seroprevalence using a cutoff titer of 1:800 was 33.1, 36.5 and 85.7% during the three consecutive pregnancies. The antibody titers of individual cows fluctuated over time. Abortion rates and the rate of removal from the herd were significantly higher in seropositive cows. The rate of vertical transmission increased in correlation with the dam&#x02019;s antibody titer. Immunization resulted in lower abortion rates at two of the farms. Vaccine efficacy ranged from a negative effect to 54% at different farms, with an overall efficacy of 10.4%. The effect of vaccination on abortions, reproductive performance, antibody titers, vertical transmission and removal from the herd was not significant. Conclusions: These results demonstrate varying vaccine efficacies among farms and suggest that neosporosis is a multifactorial disease that cannot be solely controlled by vaccination.</p></abstract><kwd-group><kwd><italic toggle="yes">Neospora caninum</italic></kwd><kwd>neosporosis</kwd><kwd>abortion</kwd><kwd>cattle</kwd><kwd>vaccination</kwd><kwd>control</kwd><kwd>vertical transmission</kwd><kwd>horizontal transmission</kwd></kwd-group><funding-group><award-group><funding-source>The Israeli Dairy Board</funding-source><award-id>851-0353-21</award-id></award-group><award-group><funding-source>Israeli Veterinary Services and Animal Health</funding-source></award-group><funding-statement>This research was funded by the Israeli Dairy Board, grant number 851-0353-21, and by Israeli Veterinary Services and Animal Health, Israel.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-13-00131"><title>1. Introduction</title><p><italic toggle="yes">Neospora caninum</italic> is a cyst-forming coccidia, an intracellular parasite with a heteroxenous life cycle that includes canids as its definitive host and a wide variety of mammalian species as its intermediate hosts [<xref rid="B1-vaccines-13-00131" ref-type="bibr">1</xref>,<xref rid="B2-vaccines-13-00131" ref-type="bibr">2</xref>]. Most intermediate hosts do not exhibit clinical signs, and the main clinical consequence of <italic toggle="yes">Neospora</italic> infection is an increased risk of abortion [<xref rid="B1-vaccines-13-00131" ref-type="bibr">1</xref>]. Neosporosis has been reported in most parts of the word with varying prevalence, and its main economic significance is in its role as a cause of abortions in cattle [<xref rid="B3-vaccines-13-00131" ref-type="bibr">3</xref>].</p><p>Cattle may become infected with <italic toggle="yes">Neospora</italic> via horizonal transmission, that is, through the ingestion of oocysts secreted by definitive canid hosts [<xref rid="B1-vaccines-13-00131" ref-type="bibr">1</xref>,<xref rid="B4-vaccines-13-00131" ref-type="bibr">4</xref>]. However, vertical transmission is considered the main route of transmission in cattle. Thus, high rates of pregnant infected cows that do not experience abortion lead to the calving of apparently healthy infected calves [<xref rid="B4-vaccines-13-00131" ref-type="bibr">4</xref>,<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>,<xref rid="B6-vaccines-13-00131" ref-type="bibr">6</xref>,<xref rid="B7-vaccines-13-00131" ref-type="bibr">7</xref>].</p><p>These calves become <italic toggle="yes">Neospora</italic> carrier cows, which have an increased risk of abortions [<xref rid="B8-vaccines-13-00131" ref-type="bibr">8</xref>] and repeated abortions in subsequential pregnancies [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>]. The risk of abortion increases in correlation with the anti-<italic toggle="yes">Neospora</italic> antibody titer [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>,<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-13-00131" ref-type="bibr">10</xref>]. It has been suggested that immunosuppression during pregnancy may lead to the re-emergence of parasites from tissues cysts and transient parasitemia, which may infect the fetus [<xref rid="B11-vaccines-13-00131" ref-type="bibr">11</xref>]. Its high rates of vertical transmission in combination with its long-term effect on reproductive performance may lead to an increased prevalence and cumulative economic effect of neosporosis in some herds, making prevention and control attempts challenging.</p><p>No effective chemotherapy or commercial vaccine is currently available for neosporosis. Since <italic toggle="yes">Neospora</italic> is an intracellular parasite, effective immune response is based mainly on cell-mediated immunity, while the presence of specific antibodies has not proven to be protective [<xref rid="B12-vaccines-13-00131" ref-type="bibr">12</xref>,<xref rid="B13-vaccines-13-00131" ref-type="bibr">13</xref>]. Several attempts have been made to produce an effective vaccine against neosporosis using specific antigens, tachyzoite lysate or live tachyzoites, with part of them showing promising preliminary results in mice and cattle [<xref rid="B14-vaccines-13-00131" ref-type="bibr">14</xref>,<xref rid="B15-vaccines-13-00131" ref-type="bibr">15</xref>,<xref rid="B16-vaccines-13-00131" ref-type="bibr">16</xref>,<xref rid="B17-vaccines-13-00131" ref-type="bibr">17</xref>,<xref rid="B18-vaccines-13-00131" ref-type="bibr">18</xref>,<xref rid="B19-vaccines-13-00131" ref-type="bibr">19</xref>,<xref rid="B20-vaccines-13-00131" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-13-00131" ref-type="bibr">21</xref>]. However, a previous commercial vaccine, Bovilis<sup>&#x000ae;</sup> Neoguard, a killed <italic toggle="yes">Neospora caninum</italic> tachyzoite vaccine (Intervet International B.V., Boxmeer, The Netherlands), only demonstrated moderate protection against abortions and was discontinued [<xref rid="B22-vaccines-13-00131" ref-type="bibr">22</xref>,<xref rid="B23-vaccines-13-00131" ref-type="bibr">23</xref>].</p><p>Recently, a live attenuated vaccine was developed using the Israeli <italic toggle="yes">N. caninum</italic> isolate (NcIs491) [<xref rid="B24-vaccines-13-00131" ref-type="bibr">24</xref>]. This vaccine has been evaluated using a vaccination approach where only seropositive cows were vaccinated at mid-pregnancy (between 120 and 140 days of pregnancy). This approach aimed to increase immune protection at the stage of immunomodulation during pregnancy in order to prevent parasite re-emergence and any risk of infection of the fetus. The preliminary results under field conditions demonstrated an efficacy of 39% in preventing abortions when using fresh&#x02013;live vaccination [<xref rid="B25-vaccines-13-00131" ref-type="bibr">25</xref>], and an efficacy of 28.4% when using a frozen&#x02013;live vaccine [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>]. In the latter study, the live vaccine was kept frozen in liquid nitrogen to provide easier storage and use in the field, which could be implemented in the future by veterinary practitioners. The efficacy of the frozen&#x02013;live vaccine varied between farms, suggesting that environmental and husbandry factors may affect the efficacy of vaccination in preventing abortions.</p><p>The current study was set to re-evaluate the efficacy of frozen&#x02013;live vaccination during pregnancy in preventing abortions, as well as to evaluate whether single vaccination has a long-term effect on more than one pregnancy or if re-vaccination is necessary during each pregnancy. Therefore, this study was designed as a long-term study following the same cohort of cows during three consecutive pregnancies, evaluating <italic toggle="yes">Neospora</italic> serological status at each pregnancy, vaccinating seropositive cows and documenting the outcome of each pregnancy.</p></sec><sec id="sec2-vaccines-13-00131"><title>2. Materials and Methods</title><sec id="sec2dot1-vaccines-13-00131"><title>2.1. Study Design</title><p>The farms that participated in this study all had a history of neosporosis, which was confirmed and evaluated by a serological diagnosis of a sample of the cows in each herd. Farms were selected according to the cooperation of the farmers and the attending veterinarians. All farms used computerized monitoring for their animals, which made all the relevant data available. This study was conducted at five farms between November 2020 and May 2023. One of the farms (Farm 5) had also been included in the preliminary study, with a vaccine efficacy (VE) of 75% [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>]. One farm (Farm 4) was removed from the study due to a lack of cooperation. Another farm (Farm 6) was added to the study in May 2022 in place of Farm 4.</p><p>The study population comprised 1059 heifers, between 116 and 450 from each farm, which were first sampled on day 110&#x02013;120 of their first pregnancy and re-sampled in the same timeframe during their consecutive pregnancy. The timing of sample collection was selected to represent the stage of the pregnancy in which physiological immunosuppression may evoke the re-emergence of parasites and an increase in antibody titer, which reflects the risk of abortion. In addition, sampling took place following the confirmation of pregnancy at the end of the first trimester [<xref rid="B11-vaccines-13-00131" ref-type="bibr">11</xref>]. Cows were screened for serologic exposure to <italic toggle="yes">Neospora</italic> spp. Using the indirect fluorescent antibody test (IFAT). Since parasitemia is short and transient, the antibody levels reflect exposure to <italic toggle="yes">Neospora</italic>, and generally correspond to parasite load. Only seropositive cows with antibody titers higher than 1:800 were considered for vaccination, as this is the antibody titer which was previously demonstrated to be associated with an increased chance of abortion [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>].</p><p>The seropositive heifers at each farm were divided into two groups. The first group was vaccinated with <italic toggle="yes">N. caninum</italic> live frozen tachyzoites on days 120&#x02013;140 of pregnancy, while the second group served as unvaccinated controls and no treatment was administered. All cows in the unvaccinated group remained unvaccinated throughout the study period. Half of the vaccinated cows were re-vaccinated during their second pregnancy, while the other half were not re-vaccinated (<xref rid="vaccines-13-00131-f001" ref-type="fig">Figure 1</xref>).</p><p>Data were collected regarding the outcome of all pregnancies, the number of inseminations required to achieve each pregnancy and the date and reason for removal from the herd (when relevant). To evaluate the rate of vertical transmission, two of the farms (Farms 1 and 2) collected blood samples from the calves born to the cows included in this study prior to their ingestion of colostrum to further the serological analyses, as the bovine placenta is impermissible to the transfer of antibodies [<xref rid="B26-vaccines-13-00131" ref-type="bibr">26</xref>].</p><p>This study was conducted upon the owners&#x02019; consent and was approved by the Animal Experiments Welfare Committee of the Kimron Veterinary Institute (020_b18181_6).</p></sec><sec id="sec2dot2-vaccines-13-00131"><title>2.2. Sample Collection and Serological Testing</title><p>Pregnancy examinations were performed on days 110 to 120 after insemination by the attending veterinarians using the fetal membrane slip method, and blood was collected from the tail vein of all pregnant cows into a sterile serum collection tube without anticoagulants. Blood was collected from the jugular vein of newborn calves prior to colostrum feeding. All blood samples were centrifuged at 4000&#x000d7; <italic toggle="yes">g</italic> for 4 min and the serum was separated. The presence of anti-<italic toggle="yes">Neospora</italic> spp. antibodies was determined by an immunofluorescence antibody test (IFAT), as previously described [<xref rid="B27-vaccines-13-00131" ref-type="bibr">27</xref>]. The antigen was prepared in-house using culture-derived NC-1 tachyzoites with an anti-cattle IgG secondary antibody (A8917, Sigma-Aldrich, Darmstadt, Germany), and the results were interpreted using a fluorescent microscope. The highest dilution of serum exhibiting fluorescence of the whole <italic toggle="yes">Neospora</italic> organism was considered as the endpoint titer. An antibody titer of 1:200 was considered as borderline, and antibody titers of 1:800 or higher were considered positive, in concurrence with previous studies [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>,<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>,<xref rid="B25-vaccines-13-00131" ref-type="bibr">25</xref>].</p></sec><sec id="sec2dot3-vaccines-13-00131"><title>2.3. Vaccination Procedure</title><p>Vaccination was performed with doses of 2 &#x000d7; 10<sup>8</sup> live <italic toggle="yes">Neospora caninum</italic> tachyzoites administered subcutaneously on days 120&#x02013;140 post-insemination. Parasite culture and vaccine preparation were performed as previously described [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>,<xref rid="B25-vaccines-13-00131" ref-type="bibr">25</xref>]. Vaccine doses were kept frozen in liquid nitrogen until use.</p></sec><sec id="sec2dot4-vaccines-13-00131"><title>2.4. Statistical Analysis</title><p>The agreement between the serological status of two consecutive pregnancies was evaluated using Cohen&#x02019;s kappa.</p><p><italic toggle="yes">Neospora</italic> seroprevalence was compared between pregnancies. For the population of unvaccinated cows, associations between <italic toggle="yes">Neospora</italic> serological status and the rate of abortions, the rate of multiple inseminations, the rate of cows removed from the herd and the rate of cows removed from the herd due to reproduction failure to the total cows removed during each pregnancy were evaluated. The effect of the vaccination of cows with antibody titers of 1:800 or higher on abortion, the rate of multiple inseminations, the rate of cows removed from the herd and the rate of cows removed from the herd due to reproduction failure to the total cows removed during each pregnancy were evaluated. These analyses were performed using the generalized estimating equation (GEE) with a logit link function, with each sample defined as the subject and the cow as within subject effect.</p><p>The association between vaccination and vertical transmission and the effect of repeated vaccination on abortion rates was evaluated using Fisher&#x02019;s exact test and the odds ratio (OR). The correlation between the number of pregnancies and the abortion rate was estimated by Spearman&#x02019;s rho (&#x003c1;).</p><p>The effect of vaccination on the abortion rates in different farms was evaluated in the population of cows with anti-<italic toggle="yes">Neospora</italic> antibody titers of 1:800 or higher using Fisher&#x02019;s exact test and the odds ratio (OR). Vaccine efficacy (VE) was calculated using the following formula: VE = (ARU&#x02013;ARV)/ARU &#x000d7; 100 (ARU = abortion rate in unvaccinated cows; ARV = abortion rate in vaccinated cows).</p><p>The statistical significance of all analyses was set at <italic toggle="yes">p</italic> &#x0003c; 0.05. The analysis was performed using SPSS 27.0<sup>&#x000ae;</sup> (IBM Corp, Armonk, NY, USA) and Win Pepi 11.43<sup>&#x000ae;</sup> statistical software (Abramson, J.H. WINPEPI updated: computer programs for epidemiologists and their teaching potential. Epidemiologic Perspectives &#x00026; Innovations, 2011, 8:1).</p></sec></sec><sec sec-type="results" id="sec3-vaccines-13-00131"><title>3. Results</title><sec id="sec3dot1-vaccines-13-00131"><title>3.1. Neospora Seroprevalence in Heifers</title><p>A total of 1059 heifers were sampled during their first pregnancy (<xref rid="vaccines-13-00131-t001" ref-type="table">Table 1</xref>), with 116 to 450 tested at each farm. The antibody titers on days 110&#x02013;120 of the first pregnancy ranged between 0 and 1:12,800, with a median of 200 and an interquartile range (IQR) of 800. The overall seroprevalence of neosporosis in heifers, including heifers with borderline titers, was 60.8% [644 of 1059; 95% confidence interval (CI): 57.8&#x02013;63.77], and ranged between 48 and 83% in different farms. Among them, 293 had a borderline titer of 1:200 (27.7%), while 33.1% had titers of 800 or higher (95% CI: 30.3&#x02013;36.1, <xref rid="vaccines-13-00131-f002" ref-type="fig">Figure 2</xref>), between 18 and 63% in each farm. Out of the 351 seropositive heifers, 173 were vaccinated on days 120&#x02013;140 of the same pregnancy (<xref rid="vaccines-13-00131-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3dot2-vaccines-13-00131"><title>3.2. Dynamics of Anti-Neospora Serological Titers in Repeated Samples of Individual Cows</title><p>Out of the 1059 heifers that were sampled during their first pregnancy, 260 were sampled at least twice and 21 of these were sampled three times. Out of these 260 cows, 116 had a titer of 1:800 or higher during their first pregnancy, 62 of which were vaccinated. A total of 198 unvaccinated cows were re-sampled during one consecutive pregnancy and 11 were sampled during two additional pregnancies.</p><p>Among the seronegative heifers (n = 83), 63.8% remained negative in their second pregnancy, while 31.3% seroconverted to a borderline titer and 4.8% became seropositive. Of the heifers with a borderline titer, 26.2% maintained the same antibody titer, while 59.0% tested negative and 14.7% showed an increase in their antibody titer to at least 1:800. Lastly, of the heifers that tested with a high antibody titer of at least 1:800, 68.5% maintained their high antibody titer, 16.7% had a decreased antibody titer of 1:200 (borderline titer) and 14.8% tested negative during their second pregnancy (<xref rid="vaccines-13-00131-t002" ref-type="table">Table 2</xref>).</p><p>When considering the borderline titer of 1:200 as a cutoff, the agreement between the serological results on the two consecutive pregnancies was fair (Cohen&#x02019;s kappa = 0.32; 68.46% agreement). When setting the cutoff at a titer of 1:800, the agreement between the serological results on the two consecutive pregnancies was substantial (Cohen&#x02019;s kappa = 0.63; 81.92% agreement).</p><p>Exploring the fluctuations in antibody titers in the 21 cows that were sampled during three pregnancies revealed that most cows maintained their serological status (negative, borderline or positive); however, the titers did fluctuate between pregnancies, including cases of seroconversion from negative to positive or from positive to negative (<xref rid="vaccines-13-00131-t003" ref-type="table">Table 3</xref>).</p><p>Out of the 62 vaccinated cows that were sampled twice, 10 (16.1%) had an increase in their antibody titer in their next pregnancy, the titer of 24 cows (38.7%) remained constant, and 28 cows (45.2%) had a decrease in their antibody titer. Out of these, nine cows (14.5%) dropped to a borderline titer and another nine (14.5%) were seronegative in their next pregnancy following vaccination. The distribution of antibody titers during the second pregnancy did not differ between seropositive cows vaccinated during their previous pregnancy and unvaccinated seropositive cows (<italic toggle="yes">p</italic> = 0.662).</p></sec><sec id="sec3dot3-vaccines-13-00131"><title>3.3. Vertical Transmission</title><p>Blood samples were collected from 136 calves of the cows participating in this study before ingestion of colostrum (<xref rid="vaccines-13-00131-t004" ref-type="table">Table 4</xref>). There was a significant positive correlation between the antibody titers of dams and their calves (&#x003c1; = 0.679, <italic toggle="yes">p</italic> &#x0003c; 0.001). The incidence of seropositive calves born to a seronegative dam was very low (3.2%, 1 of 31 of seronegative dams), and it had a borderline titer. The rate of vertical transmission among dams with a borderline antibody titer (1:200) was 37.2% (16 of 43 calves, of which 6 presented a borderline titer and 10 had high antibody titers). The rate of vertical transmission from dams with high antibody titers (&#x02265;1:800) was 87.1% (54 of 62 calves), with three presenting a borderline titer and the majority presenting an antibody titer 1:800 or higher (51 calves, 82.3%). Of the 62 dams with high antibody titers, 29 were vaccinated during their current pregnancy and 33 were not vaccinated. Of the 33 calves of the unvaccinated dams, 6 were seronegative (18.2%), 1 had a titer of 1:200 (3.0%) and the rest had a titer of at least 1:800 (26 calves, 78.8%). Among the calves of the vaccinated dams, two were seronegative (6.9%), two had an antibody titer of 1:200 (6.9%) and the rest had a titer of at least 1:800 (25 calves, 86.2%). There was no significant difference in vertical transmission rates between the vaccinated and unvaccinated dams when considering a diagnostic cutoff of 1:200 (<italic toggle="yes">p</italic> = 0.264) or when setting it at 1:800 (<italic toggle="yes">p</italic> = 0.445). In addition, there was no significant difference in the distribution of the calf antibody titers from vaccinated and unvaccinated dams (<italic toggle="yes">p</italic> = 0.698).</p><p>Five of the dams had twins. Of them, three negative dams had only negative calves. A dam with a titer of 1:800 (not vaccinated) had two calves with a titer of 1:12,800. A dam with a titer of 1:3200 (not vaccinated) had one calf with a titer of 1:800 and another with a titer of 1:3200. Each of these cases was only included in the <xref rid="vaccines-13-00131-t004" ref-type="table">Table 4</xref> as one incidence, using the higher calf titer.</p></sec><sec id="sec3dot4-vaccines-13-00131"><title>3.4. Reproduction Parameters and Removal from the Herd</title><p>Data were obtained regarding the 2027 pregnancies of the 1059 cows included in this study. Of these, blood samples were collected in 1342 pregnancies and the outcome of the pregnancy (normal calving or abortion) was recorded for 1475 of the pregnancies. The data presented here did not differentiate between seropositive vaccinated and unvaccinated cows as the vaccine was not associated with any of these parameters (<xref rid="sec3dot6-vaccines-13-00131" ref-type="sec">Section 3.6</xref>).</p><p>The reported number of inseminations required to achieve each pregnancy ranged between one and eleven (median = 2; IQR = 3). Pregnancies with up to two inseminations were considered as &#x0201c;normal&#x0201d;, and three inseminations or more were considered as &#x0201c;multiple inseminations&#x0201d;, which may suggest difficulty to conceive. Of 2024 pregnancies, 1161 (57.3%) had less than three inseminations, while 862 (42.6%) had multiple inseminations. The rate of multiple insemination in the cows&#x02019; first four pregnancies was significantly higher in the second pregnancy (50.4%) than the first (36.6%); however, the third and fourth pregnancies did not differ significantly from the first two (<xref rid="vaccines-13-00131-t005" ref-type="table">Table 5</xref>).</p><p>A total of 1302 of the 1475 pregnancies with recorded outcome resulted in normal calving (88.3%), while 173 (11.7%) resulted in abortion. In 53 cases, a history of previous abortion was recorded prior to first sampling (therefore, these cows were still considered as heifers). The rate of abortions increased from 8.5% during the first pregnancy to 46.2% in the third pregnancy and was significantly higher during each consecutive pregnancy (all <italic toggle="yes">p</italic> &#x0003c; 0.001, <xref rid="vaccines-13-00131-t006" ref-type="table">Table 6</xref>). A positive correlation was found between the number of pregnancies and the rate of abortions (&#x003c1; = 0.171, <italic toggle="yes">p</italic> &#x0003c; 0.001).</p><p>Two hundred and four cows (19.3%) were removed from the herd during the study period. The reasons for removal from the herd were diverse. A total of 6 cows were reported as &#x0201c;dead&#x0201d;, 14 were sold for economic purposes, 10 suffered from infectious diseases (paratuberculosis, mycoplasmosis, bovine ephemeral fever), 6 suffered from trauma, 41 had low milk production and others had various orthopedic, metabolic or other veterinary conditions. A total of 60 of the cows (29.4%) were removed for reasons relating to reproductive problems, including 35 due to abortion, 2 following dystocia and 23 on account of failure to conceive. Of the total cows removed from the herd, 100 (49.0%) were removed during their first pregnancy, 97 (47.5%) during their second pregnancy, and 7 (3.4%) during their third pregnancy. Of the 60 cows removed due to reproductive failure, 27 (45.0%) were removed during their first pregnancy, 29 (48.3%) during their second pregnancy, and 4 (6.7%) during their third pregnancy. The total rate of removal from the herd (<italic toggle="yes">p</italic> = 0.058) and the percentage of cows removed from the herd on account of reproductive failure (<italic toggle="yes">p</italic> = 0.245) did not differ significantly between pregnancies.</p></sec><sec id="sec3dot5-vaccines-13-00131"><title>3.5. Neosporosis Impact on Reproduction Parameters and Performance</title><p>The rate of multiple inseminations did not differ in relation to <italic toggle="yes">Neospora</italic> serological status. The rate of removal from the herd was higher in seropositive or borderline cows than in seronegative cows (<italic toggle="yes">p</italic> &#x0003c; 0.001) but was not significantly different between high and low antibody titers (<italic toggle="yes">p</italic> = 0.487). The rate of removal from the herd due to reduced fertility, although higher in pregnancies with high antibody titers, did not differ significantly between serological groups (<xref rid="vaccines-13-00131-t007" ref-type="table">Table 7</xref>).</p><p>The outcome of pregnancy was available for 1238 of 1342 pregnancies, in which blood samples were collected from 1016 cows. Of these cows, 797 were sampled during one pregnancy, 216 during two pregnancies and 3 during three pregnancies. Out of 420 pregnancies in which cows had high anti-<italic toggle="yes">Neospora</italic> antibody titers, 193 were vaccinated during their pregnancy. The total abortion rate within unvaccinated pregnancies was 7.8% (82 of 1045 pregnancies, <xref rid="vaccines-13-00131-t008" ref-type="table">Table 8</xref>). Abortion rates in unvaccinated pregnancies significantly correlated with their antibody titer, were higher in cows with borderline antibody titers than in seronegative cows (<italic toggle="yes">p</italic> = 0.008), and were significantly higher in cows with high antibody titers than in ones with low antibody titers (<italic toggle="yes">p</italic> &#x0003c; 0.001, <xref rid="vaccines-13-00131-t007" ref-type="table">Table 7</xref>).</p></sec><sec id="sec3dot6-vaccines-13-00131"><title>3.6. Variations Between Farms</title><p>The rate of abortions in different farms ranged between 6.6 and 19.8% of unvaccinated cows. The rate of abortion was associated with the prevalence of neosporosis at each farm (<italic toggle="yes">p</italic> &#x0003c; 0.001, <xref rid="vaccines-13-00131-t009" ref-type="table">Table 9</xref>). The rates of multiple inseminations, removal from the herd and removal due to reduced fertility did not differ significantly between farms (<xref rid="vaccines-13-00131-t008" ref-type="table">Table 8</xref>).</p></sec><sec id="sec3dot7-vaccines-13-00131"><title>3.7. The Effect of Vaccination on Reproductive Performance</title><p>In an evaluation of the overall effect of vaccination in pregnancies in which antibody titers of 1:800 or higher were measured, no significant difference between vaccinated and unvaccinated cows was detected within abortion rates (<italic toggle="yes">p</italic> = 0.607), multiple inseminations (<italic toggle="yes">p</italic> = 0.744), vertical transmission (<italic toggle="yes">p</italic> = 0.445) or removal from the herd for any reason (<italic toggle="yes">p</italic> = 0.305), or for reasons relating to reproductive performance (<italic toggle="yes">p</italic> = 0.651) (<xref rid="vaccines-13-00131-t007" ref-type="table">Table 7</xref>).</p><p>A comparison of the abortion rates in vaccinated and vaccinated cows revealed lower abortion rates in the entire vaccinated group, and in two of the farms. However, none of these differences were statistically significant. The overall vaccine efficacy in the study groups was 10.4%, and the vaccine efficacy in different farms ranged between 54% and &#x02212;167%. The efficacy of vaccination in preventing abortion was not significant in any of the farms (<xref rid="vaccines-13-00131-t009" ref-type="table">Table 9</xref>).</p><p>Of the 173 cows that were vaccinated as heifers, 23 were re-vaccinated during their second pregnancy. Although 94 of the 351 heifers with high antibody titers were re-sampled, in some cases, there was a decrease in the antibody titer in the second pregnancy, which made them ineligible for vaccination. There was no significant difference in the abortion rates between the cows that were sampled at least twice and were vaccinated once or twice (over two consecutive pregnancies) (<italic toggle="yes">p</italic> = 0.946, <xref rid="vaccines-13-00131-t010" ref-type="table">Table 10</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-vaccines-13-00131"><title>4. Discussion</title><p>The main aim of this study was to evaluate the long-term efficacy of anti-<italic toggle="yes">Neospora</italic> vaccination during consecutive pregnancies in naturally infected dams. The overall efficacy of either single vaccination or re-vaccination in preventing abortions was not significant. However, the data collected during this study provide detailed observations into the epidemiology of neosporosis in endemic farms.</p><p>The overall prevalence of neosporosis in the study population was 60.8% (95% CI: 57.8&#x02013;63.77), which was higher than previous reports from Israel (44.3% [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>], 41.4% [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>]), perhaps since highly endemic farms were targeted for participation in this study. However, the prevalence of 33.1% of cows with antibody titers of 1:800 or higher (95% CI: 30.1&#x02013;36.1%) was similar or slightly higher than previous reports from the area (35.5% [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>], 25.1% [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>]).</p><p>It has been shown in previous studies, as well as in the current one, that there is a positive correlation between anti-<italic toggle="yes">Neospora</italic> antibody titers and the risk of abortion [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>,<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>,<xref rid="B28-vaccines-13-00131" ref-type="bibr">28</xref>]. Previously, a titer of 1:200 was not associated with an increased risk of abortions [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>,<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>,<xref rid="B28-vaccines-13-00131" ref-type="bibr">28</xref>], and therefore, in several studies, as well as in the current and previous vaccine trials, a titer of 1:200 was considered as &#x0201c;borderline&#x0201d;, and the &#x0201c;clinically relevant&#x0201d; titer was set at 1:800.</p><p>The clinical significance of <italic toggle="yes">Neospora</italic> carriage is associated with an increased risk of abortions, but also the risk of vertical transmission. Vertical transmission is considered as the main route of transmission in endemic herds [<xref rid="B7-vaccines-13-00131" ref-type="bibr">7</xref>,<xref rid="B29-vaccines-13-00131" ref-type="bibr">29</xref>,<xref rid="B30-vaccines-13-00131" ref-type="bibr">30</xref>], and is therefore crucial for the maintenance of neosporosis within a population. Hence, the rate of potential vertical transmission should be taken into consideration in the implementation of control programs. Several previous studies have demonstrated that the rate of vertical transmission is higher in cows with high antibody titers than in cows with &#x0201c;borderline&#x0201d; or low titers [<xref rid="B29-vaccines-13-00131" ref-type="bibr">29</xref>,<xref rid="B30-vaccines-13-00131" ref-type="bibr">30</xref>], and may be up to 95%. Similar findings were recorded in this study, where a significant positive correlation was found between the dam and calf&#x02019;s antibody titers (&#x003c1; = 0.679, <italic toggle="yes">p</italic> &#x0003c; 0.001) based on a relatively large sample size (N = 136). On one hand, these findings strengthen the conclusion that an antibody titer of 1:800 is, indeed, more clinically significant both regarding abortion rates and vertical transmission. However, on the other hand, 16 of 43 calves (37.2%) born to dams with antibody titers of 1:200 were born seropositive, most of which had high titers (10 of the 16). Therefore, these &#x0201c;borderline&#x0201d; cows, although not prone to abortion, may still contribute to the circulation of neosporosis in the herd. This contribution should be taken into consideration when constructing control programs in infected herds, and the selection of a testing method should be made accordingly.</p><p>In this study, we aimed to assess whether <italic toggle="yes">Neospora</italic> carriage may also affect fertility by estimating its association with multiple inseminations. Failure to conceive may be attributed to numerous factors which may either affect the chance to conceive, affect the chance to maintain pregnancy, or reflect early embryonic death. An evaluation of 1045 pregnancies did not reveal any significant association between <italic toggle="yes">Neospora</italic> serological status and the risk of multiple inseminations. These findings concur with the hypothesis that the dam&#x02019;s cellular immunity is efficient during this stage of pregnancy and that infection or the re-emergence of parasites during this stage are unlikely to result in early abortion, as well as that most <italic toggle="yes">Neospora</italic>-related abortions occur in the second trimester, when cellular immunity is suppressed [<xref rid="B11-vaccines-13-00131" ref-type="bibr">11</xref>,<xref rid="B31-vaccines-13-00131" ref-type="bibr">31</xref>], in contrast to recent results from Brazil [<xref rid="B32-vaccines-13-00131" ref-type="bibr">32</xref>].</p><p>Similarly to previous studies [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>,<xref rid="B25-vaccines-13-00131" ref-type="bibr">25</xref>], abortion rates increased in relation to the number of pregnancies, regardless of the <italic toggle="yes">Neospora</italic> serological status, with higher rates of abortions in older cows. Nevertheless, abortion rates were higher in seropositive cows, regardless of the number of pregnancies. Similarly, the chance of multiple insemination was higher in the second pregnancy than in the first, although the difference did not remain significant in later pregnancies. It appears that neosporosis in the herd affects both younger and older cows, and its influence does not subside with age [<xref rid="B5-vaccines-13-00131" ref-type="bibr">5</xref>].</p><p>Most cows maintained their serological status during consecutive pregnancies; however, fluctuations in antibody titers were observed. The incidence of horizontal transmission was evaluated with the inspection of the serological status of individual cows in consecutive pregnancies. Seroconversion was detected in 36.1% of seronegative cows; however, only a few (4 of 53) had high antibody titers. These cases with low antibody titers may be new infections in early stages or may reflect fluctuations in the antibody titers in cows with low antibody levels, which set them below the cutoff for detection, as also seen in the numerous cases of cows with a titer of 1:200 that converted to negative. In addition, some new infections in na&#x000ef;ve cows may be resolved without resulting in their transformation to a carrier state. In total, only 13 of 144 seronegative or &#x0201c;borderline&#x0201d; cows had an antibody titer of 1:800 or higher in a future pregnancy, an incidence of 9% of horizontal transmission.</p><p>Almost 20% of the study population was removed from the herd during the study period. Cows were removed for a variety of reasons, with 29.4% due to reasons relating to reproductive performance. Although abortion rates increased with the number of pregnancies, neither the total rate of removal nor removal due to reproductive failure differed significantly between pregnancies. Interestingly, the rate of removal from the herd was higher in the seropositive than in the seronegative cows, regardless of their antibody titers. This rate may have been influenced by the serological testing during this study, since the farm owners were not blinded to the serological test results during the study. This selective removal (whether intentional or not) may have influenced the results of this study, reducing the sample size in consecutive pregnancies, especially in the group of positive, unvaccinated cows.</p><p>Vaccination is the main approach to control neosporosis, since no effective treatment is currently available, with increasing research and vaccine trials [<xref rid="B33-vaccines-13-00131" ref-type="bibr">33</xref>]. Several inactivated and attenuated vaccines have been developed against neosporosis [<xref rid="B11-vaccines-13-00131" ref-type="bibr">11</xref>,<xref rid="B14-vaccines-13-00131" ref-type="bibr">14</xref>,<xref rid="B16-vaccines-13-00131" ref-type="bibr">16</xref>,<xref rid="B17-vaccines-13-00131" ref-type="bibr">17</xref>,<xref rid="B20-vaccines-13-00131" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-13-00131" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-13-00131" ref-type="bibr">22</xref>,<xref rid="B23-vaccines-13-00131" ref-type="bibr">23</xref>,<xref rid="B25-vaccines-13-00131" ref-type="bibr">25</xref>,<xref rid="B34-vaccines-13-00131" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-13-00131" ref-type="bibr">35</xref>]; however, the use of live parasites of less pathogenic or attenuated strains is considered as the more suitable approach in order to induce the cellular immunity required to effectively eliminate infection. A number of vaccine trials have shown promising effects in preventing abortions following infection during pregnancy [<xref rid="B14-vaccines-13-00131" ref-type="bibr">14</xref>,<xref rid="B21-vaccines-13-00131" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-13-00131" ref-type="bibr">22</xref>,<xref rid="B23-vaccines-13-00131" ref-type="bibr">23</xref>,<xref rid="B25-vaccines-13-00131" ref-type="bibr">25</xref>]; however, the efficacy of vaccination in cases of the re-emergence of parasites in carrier animals is uncertain. Vaccine trials carried out under field conditions in endemic herds demonstrated relatively low and inconsistent efficacy, with considerable variation between farms [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>,<xref rid="B23-vaccines-13-00131" ref-type="bibr">23</xref>].</p><p>In the current study, the efficacy of vaccination in preventing abortions was 10.4%, lower than in the previous trials using the same vaccination protocol (39% [<xref rid="B25-vaccines-13-00131" ref-type="bibr">25</xref>] and 28.4% [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>]). Vaccination did not affect the antibody titers in the following pregnancies, and did not reduce the risk of vertical transmission. Vaccine efficacy varied considerably between farms, similarly to a previous trial [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>]. In all farms, neosporosis was associated with abortion rates, while multiple insemination rates and removal from the herd did not differ significantly among farms. Vaccine efficacy in different farms varied between 54 and &#x02212;167% and was not significant in any of the farms. Interestingly, the farm (Farm 5) that demonstrated a significant vaccine efficacy of 75% (<italic toggle="yes">p</italic> = 0.005) in a previous study [<xref rid="B9-vaccines-13-00131" ref-type="bibr">9</xref>] had slightly higher abortion rates in the vaccinated group in this study (VE = &#x02212;5%). These results may suggest that farm management is not the only contributing factor to the variation in vaccine efficacy and that other environmental or health events may be involved, such as the presence of other infectious diseases or horizontal transmission events. It has been suggested that there might be a concurrent effect between <italic toggle="yes">Neospora</italic> and bovine viral diarrhea infections, which would lead to a higher chance of co-infection and of related abortions [<xref rid="B36-vaccines-13-00131" ref-type="bibr">36</xref>]. During the study period of the current study, there were reported cases of bovine ephemeral fever and an abortion wave due to the introduction of neosporosis into the heifer group in Farm 5. Although these events did not directly affect the study group, the circulation of other infectious diseases in the farm may have had some influence on the immunity of the herd, changing the equilibrium between the parasites and immune response of individual cows, leading to increased abortions and/or vertical transmission rates, which could not be prevented by vaccination.</p><p>The use of live vaccines leads to infection with attenuated strains, which should induce protective immunity against more virulent strains. The disadvantage of live attenuated vaccines is the risk of infecting na&#x000ef;ve animals, which may also increase the rate of vertical transmission in the herd. Most vaccination trials did not address this issue; however, one study did report an increased occurrence of vertical transmission in vaccinated animals [<xref rid="B23-vaccines-13-00131" ref-type="bibr">23</xref>]. In the current study, no difference was found between the rate of vertical transmission and the calves&#x02019; antibody titers in vaccinated versus unvaccinated cows (<italic toggle="yes">p</italic> = 0.698). The fact that vaccination did not increase the risk of vertical transmission arises from the study design, in which only seropositive cows were vaccinated. Hence, there was no chance of seroconversion, which could lead to vertical transmission due to vaccination. However, since increased protection during the critical stage of pregnancy should, theoretically, also reduce the rate of vertical transmission (since both abortion and the delivery of an infected calf are the possible results of in utero infection of the fetus), this type of protection was not observed, but may coincide with the non-significant effect of vaccination on abortion in this study.</p><p>One of the aims of this study was to compare the efficacy of a single vaccination regime with repeated vaccination during subsequent pregnancies. Unfortunately, this aim was not achieved since the efficacy of the single vaccination was not significant. Therefore, the duration of protection could not be evaluated. Since this study was conducted under field conditions with no interference with farm management, there was some loss of follow-up and a substantial rate of removal from the herd. In addition, an outbreak of bovine ephemeral fever occurred in Israel during the study period and affected some of the farms. These limitations, which made the results more difficult to interpret, also represent the actual conditions affecting the use of vaccination in the field and highlight the complexity of the epidemiology of neosporosis in endemic areas. This complex epidemiology is the reason for the limited effectiveness of past vaccines when used in endemic herds [<xref rid="B20-vaccines-13-00131" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-13-00131" ref-type="bibr">21</xref>,<xref rid="B33-vaccines-13-00131" ref-type="bibr">33</xref>].</p></sec><sec sec-type="conclusions" id="sec5-vaccines-13-00131"><title>5. Conclusions</title><p>The results of this study suggest that the vaccination of carrier cows mid-pregnancy is not a sufficient measure to control neosporosis in endemic herds. The balance between parasite re-emergence and immune response during pregnancy may be affected by numerous environmental and infectious factors, which cannot be overcome by vaccination alone. In addition, vertical transmission rates in vaccinated cows and in cows with low antibody titers (which may not be detected in all testing protocols) should be considered when constructing and implementing control programs in endemic herds.</p></sec></body><back><ack><title>Acknowledgments</title><p>To Avi Meir, for his assistence in collecting the samples, and to the farm personnel for their assistance and record keeping.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.L.M.; formal analysis, S.T.-L.; investigation, E.B., J.J.D., D.Y.-L. and S.T.-L.; resources, M.L.M.; data curation, Y.L. and S.T.-L.; writing&#x02014;original draft preparation, S.T.-L.; writing&#x02014;review and editing, M.L.M. and S.T.-L.; supervision, M.L.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was conducted upon owners&#x02019; consent and approved by the Animal Experiments Welfare Committee of the Kimron Veterinary Institute (020_b18181_6).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available on request from the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-13-00131"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>J.</given-names></name>
<name><surname>Hemphill</surname><given-names>A.</given-names></name>
<name><surname>Calero-Bernal</surname><given-names>R.</given-names></name>
<name><surname>Schares</surname><given-names>G.</given-names></name>
</person-group><source>Neosporosis in Animals</source><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2017</year></element-citation></ref><ref id="B2-vaccines-13-00131"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Review of <italic toggle="yes">Neospora caninum</italic> and neosporosis in animals</article-title><source>Korean J. Parasitol.</source><year>2003</year><volume>41</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.3347/kjp.2003.41.1.1</pub-id><pub-id pub-id-type="pmid">12666725</pub-id>
</element-citation></ref><ref id="B3-vaccines-13-00131"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reichel</surname><given-names>M.P.</given-names></name>
<name><surname>Ayanegui-Alc&#x000e9;rreca</surname><given-names>M.A.</given-names></name>
<name><surname>Gondim</surname><given-names>L.F.</given-names></name>
<name><surname>Ellis</surname><given-names>J.T.</given-names></name>
</person-group><article-title>What is the global economic impact of <italic toggle="yes">Neospora caninum</italic> in cattle&#x02013;the billion dollar question</article-title><source>Int. J. Parasitol.</source><year>2013</year><volume>43</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2012.10.022</pub-id><pub-id pub-id-type="pmid">23246675</pub-id>
</element-citation></ref><ref id="B4-vaccines-13-00131"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>J.P.</given-names></name>
<name><surname>Schares</surname><given-names>G.</given-names></name>
</person-group><article-title>Neosporosis in animals--the last five years</article-title><source>Vet. Parasitol.</source><year>2011</year><volume>180</volume><fpage>90</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2011.05.031</pub-id><pub-id pub-id-type="pmid">21704458</pub-id>
</element-citation></ref><ref id="B5-vaccines-13-00131"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mazuz</surname><given-names>M.L.</given-names></name>
<name><surname>Fish</surname><given-names>L.</given-names></name>
<name><surname>Reznikov</surname><given-names>D.</given-names></name>
<name><surname>Wolkomirsky</surname><given-names>R.</given-names></name>
<name><surname>Leibovitz</surname><given-names>B.</given-names></name>
<name><surname>Savitzky</surname><given-names>I.</given-names></name>
<name><surname>Golenser</surname><given-names>J.</given-names></name>
<name><surname>Shkap</surname><given-names>V.</given-names></name>
</person-group><article-title>Neosporosis in naturally infected pregnant dairy cattle</article-title><source>Vet. Parasitol.</source><year>2014</year><volume>205</volume><fpage>85</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2014.06.009</pub-id><pub-id pub-id-type="pmid">24986462</pub-id>
</element-citation></ref><ref id="B6-vaccines-13-00131"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pare</surname><given-names>J.</given-names></name>
<name><surname>Thurmond</surname><given-names>M.C.</given-names></name>
<name><surname>Hietala</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Congenital <italic toggle="yes">Neospora caninum</italic> infection in dairy cattle and associated calfhood mortality</article-title><source>Can. J. Vet. Res.</source><year>1996</year><volume>60</volume><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">8785719</pub-id>
</element-citation></ref><ref id="B7-vaccines-13-00131"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schares</surname><given-names>G.</given-names></name>
<name><surname>Peters</surname><given-names>M.</given-names></name>
<name><surname>Wurm</surname><given-names>R.</given-names></name>
<name><surname>Barwald</surname><given-names>A.</given-names></name>
<name><surname>Conraths</surname><given-names>F.J.</given-names></name>
</person-group><article-title>The efficiency of vertical transmission of <italic toggle="yes">Neospora caninum</italic> in dairy cattle analysed by serological techniques</article-title><source>Vet. Parasitol.</source><year>1998</year><volume>80</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/S0304-4017(98)00195-2</pub-id><pub-id pub-id-type="pmid">9870361</pub-id>
</element-citation></ref><ref id="B8-vaccines-13-00131"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nayeri</surname><given-names>T.</given-names></name>
<name><surname>Moosazadeh</surname><given-names>M.</given-names></name>
<name><surname>Sarvi</surname><given-names>S.</given-names></name>
<name><surname>Daryani</surname><given-names>A.</given-names></name>
</person-group><article-title><italic toggle="yes">Neospora caninum</italic> infection in aborting bovines and lost fetuses: A systematic review and meta-analysis</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><elocation-id>e0268903</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0268903</pub-id><pub-id pub-id-type="pmid">35604902</pub-id>
</element-citation></ref><ref id="B9-vaccines-13-00131"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mazuz</surname><given-names>M.L.</given-names></name>
<name><surname>Leibovitz</surname><given-names>B.</given-names></name>
<name><surname>Savitsky</surname><given-names>I.</given-names></name>
<name><surname>Blinder</surname><given-names>E.</given-names></name>
<name><surname>Yasur-Landau</surname><given-names>D.</given-names></name>
<name><surname>Lavon</surname><given-names>Y.</given-names></name>
<name><surname>Sharir</surname><given-names>B.</given-names></name>
<name><surname>Tirosh-Levy</surname><given-names>S.</given-names></name>
</person-group><article-title>The Effect of Vaccination with <italic toggle="yes">Neospora caninum</italic> Live-Frozen Tachyzoites on Abortion Rates of Naturally Infected Pregnant Cows</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>401</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9040401</pub-id><pub-id pub-id-type="pmid">33921584</pub-id>
</element-citation></ref><ref id="B10-vaccines-13-00131"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Villa</surname><given-names>L.</given-names></name>
<name><surname>Gazzonis</surname><given-names>A.L.</given-names></name>
<name><surname>Fumagalli</surname><given-names>E.</given-names></name>
<name><surname>Zanzani</surname><given-names>S.A.</given-names></name>
<name><surname>Manfredi</surname><given-names>M.T.</given-names></name>
</person-group><article-title>The Utility of Serological Analysis for <italic toggle="yes">Neospora caninum</italic> Infection in Dairy Cattle Farms Management: Serological Investigation and Evaluation of the Effects on Reproductive and Productive Performances in Two Study Herds in Northern Italy</article-title><source>Animals</source><year>2022</year><volume>12</volume><elocation-id>786</elocation-id><pub-id pub-id-type="doi">10.3390/ani12060786</pub-id><pub-id pub-id-type="pmid">35327183</pub-id>
</element-citation></ref><ref id="B11-vaccines-13-00131"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Innes</surname><given-names>E.A.</given-names></name>
<name><surname>Wright</surname><given-names>S.E.</given-names></name>
<name><surname>Maley</surname><given-names>S.</given-names></name>
<name><surname>Rae</surname><given-names>A.</given-names></name>
<name><surname>Schock</surname><given-names>A.</given-names></name>
<name><surname>Kirvar</surname><given-names>E.</given-names></name>
<name><surname>Bartley</surname><given-names>P.</given-names></name>
<name><surname>Hamilton</surname><given-names>C.</given-names></name>
<name><surname>Carey</surname><given-names>I.M.</given-names></name>
<name><surname>Buxton</surname><given-names>D.</given-names></name>
</person-group><article-title>Protection against vertical transmission in bovine neosporosis</article-title><source>Int. J. Parasitol.</source><year>2001</year><volume>31</volume><fpage>1523</fpage><lpage>1534</lpage><pub-id pub-id-type="doi">10.1016/S0020-7519(01)00284-3</pub-id><pub-id pub-id-type="pmid">11595240</pub-id>
</element-citation></ref><ref id="B12-vaccines-13-00131"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almeria</surname><given-names>S.</given-names></name>
<name><surname>Serrano-Perez</surname><given-names>B.</given-names></name>
<name><surname>Lopez-Gatius</surname><given-names>F.</given-names></name>
</person-group><article-title>Immune response in bovine neosporosis: Protection or contribution to the pathogenesis of abortion</article-title><source>Microb. Pathog.</source><year>2017</year><volume>109</volume><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.05.042</pub-id><pub-id pub-id-type="pmid">28578088</pub-id>
</element-citation></ref><ref id="B13-vaccines-13-00131"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dubey</surname><given-names>J.P.</given-names></name>
<name><surname>Schares</surname><given-names>G.</given-names></name>
<name><surname>Ortega-Mora</surname><given-names>L.M.</given-names></name>
</person-group><article-title>Epidemiology and control of neosporosis and <italic toggle="yes">Neospora caninum</italic></article-title><source>Clin. Microbiol. Rev.</source><year>2007</year><volume>20</volume><fpage>323</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1128/CMR.00031-06</pub-id><pub-id pub-id-type="pmid">17428888</pub-id>
</element-citation></ref><ref id="B14-vaccines-13-00131"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rojo-Montejo</surname><given-names>S.</given-names></name>
<name><surname>Collantes-Fernandez</surname><given-names>E.</given-names></name>
<name><surname>Perez-Zaballos</surname><given-names>F.</given-names></name>
<name><surname>Rodriguez-Marcos</surname><given-names>S.</given-names></name>
<name><surname>Blanco-Murcia</surname><given-names>J.</given-names></name>
<name><surname>Rodriguez-Bertos</surname><given-names>A.</given-names></name>
<name><surname>Prenafeta</surname><given-names>A.</given-names></name>
<name><surname>Ortega-Mora</surname><given-names>L.M.</given-names></name>
</person-group><article-title>Effect of vaccination of cattle with the low virulence Nc-Spain 1H isolate of <italic toggle="yes">Neospora caninum</italic> against a heterologous challenge in early and mid-gestation</article-title><source>Vet. Res.</source><year>2013</year><volume>44</volume><fpage>106</fpage><pub-id pub-id-type="doi">10.1186/1297-9716-44-106</pub-id><pub-id pub-id-type="pmid">24180373</pub-id>
</element-citation></ref><ref id="B15-vaccines-13-00131"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nishimura</surname><given-names>M.</given-names></name>
<name><surname>Kohara</surname><given-names>J.</given-names></name>
<name><surname>Kuroda</surname><given-names>Y.</given-names></name>
<name><surname>Hiasa</surname><given-names>J.</given-names></name>
<name><surname>Tanaka</surname><given-names>S.</given-names></name>
<name><surname>Muroi</surname><given-names>Y.</given-names></name>
<name><surname>Kojima</surname><given-names>N.</given-names></name>
<name><surname>Furuoka</surname><given-names>H.</given-names></name>
<name><surname>Nishikawa</surname><given-names>Y.</given-names></name>
</person-group><article-title>Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to <italic toggle="yes">Neospora caninum</italic> in cattle</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>3528</fpage><lpage>3535</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2013.05.083</pub-id><pub-id pub-id-type="pmid">23742998</pub-id>
</element-citation></ref><ref id="B16-vaccines-13-00131"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weber</surname><given-names>F.H.</given-names></name>
<name><surname>Jackson</surname><given-names>J.A.</given-names></name>
<name><surname>Sobecki</surname><given-names>B.</given-names></name>
<name><surname>Choromanski</surname><given-names>L.</given-names></name>
<name><surname>Olsen</surname><given-names>M.</given-names></name>
<name><surname>Meinert</surname><given-names>T.</given-names></name>
<name><surname>Frank</surname><given-names>R.</given-names></name>
<name><surname>Reichel</surname><given-names>M.P.</given-names></name>
<name><surname>Ellis</surname><given-names>J.T.</given-names></name>
</person-group><article-title>On the efficacy and safety of vaccination with live tachyzoites of <italic toggle="yes">Neospora caninum</italic> for prevention of <italic toggle="yes">Neospora</italic>-associated fetal loss in cattle</article-title><source>Clin. Vaccine Immunol.</source><year>2013</year><volume>20</volume><fpage>99</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1128/CVI.00225-12</pub-id><pub-id pub-id-type="pmid">23175289</pub-id>
</element-citation></ref><ref id="B17-vaccines-13-00131"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>D.J.</given-names></name>
<name><surname>Guy</surname><given-names>C.S.</given-names></name>
<name><surname>Smith</surname><given-names>R.F.</given-names></name>
<name><surname>Ellis</surname><given-names>J.</given-names></name>
<name><surname>Bjorkman</surname><given-names>C.</given-names></name>
<name><surname>Reichel</surname><given-names>M.P.</given-names></name>
<name><surname>Trees</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Immunization of cattle with live tachyzoites of <italic toggle="yes">Neospora caninum</italic> confers protection against fetal death</article-title><source>Infect. Immun.</source><year>2007</year><volume>75</volume><fpage>1343</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1128/IAI.00777-06</pub-id><pub-id pub-id-type="pmid">17145943</pub-id>
</element-citation></ref><ref id="B18-vaccines-13-00131"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>C.</given-names></name>
<name><surname>Quinn</surname><given-names>H.</given-names></name>
<name><surname>Ryce</surname><given-names>C.</given-names></name>
<name><surname>Reichel</surname><given-names>M.P.</given-names></name>
<name><surname>Ellis</surname><given-names>J.T.</given-names></name>
</person-group><article-title>Reduction in transplacental transmission of <italic toggle="yes">Neospora caninum</italic> in outbred mice by vaccination</article-title><source>Int. J. Parasitol.</source><year>2005</year><volume>35</volume><fpage>821</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2005.03.006</pub-id><pub-id pub-id-type="pmid">15885695</pub-id>
</element-citation></ref><ref id="B19-vaccines-13-00131"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haldorson</surname><given-names>G.J.</given-names></name>
<name><surname>Mathison</surname><given-names>B.A.</given-names></name>
<name><surname>Wenberg</surname><given-names>K.</given-names></name>
<name><surname>Conrad</surname><given-names>P.A.</given-names></name>
<name><surname>Dubey</surname><given-names>J.P.</given-names></name>
<name><surname>Trees</surname><given-names>A.J.</given-names></name>
<name><surname>Yamane</surname><given-names>I.</given-names></name>
<name><surname>Baszler</surname><given-names>T.V.</given-names></name>
</person-group><article-title>Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital <italic toggle="yes">Neospora caninum</italic> transmission in mice</article-title><source>Int. J. Parasitol.</source><year>2005</year><volume>35</volume><fpage>1407</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2005.05.013</pub-id><pub-id pub-id-type="pmid">16051244</pub-id>
</element-citation></ref><ref id="B20-vaccines-13-00131"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reichel</surname><given-names>M.P.</given-names></name>
<name><surname>Ellis</surname><given-names>J.T.</given-names></name>
</person-group><article-title><italic toggle="yes">Neospora caninum</italic>&#x02013;how close are we to development of an efficacious vaccine that prevents abortion in cattle?</article-title><source>Int. J. Parasitol.</source><year>2009</year><volume>39</volume><fpage>1173</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2009.05.007</pub-id><pub-id pub-id-type="pmid">19497326</pub-id>
</element-citation></ref><ref id="B21-vaccines-13-00131"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reichel</surname><given-names>M.P.</given-names></name>
<name><surname>Moore</surname><given-names>D.P.</given-names></name>
<name><surname>Hemphill</surname><given-names>A.</given-names></name>
<name><surname>Ortega-Mora</surname><given-names>L.M.</given-names></name>
<name><surname>Dubey</surname><given-names>J.P.</given-names></name>
<name><surname>Ellis</surname><given-names>J.T.</given-names></name>
</person-group><article-title>A live vaccine against <italic toggle="yes">Neospora caninum</italic> abortions in cattle</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><fpage>1299</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2015.01.064</pub-id><pub-id pub-id-type="pmid">25659274</pub-id>
</element-citation></ref><ref id="B22-vaccines-13-00131"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Romero</surname><given-names>J.J.</given-names></name>
<name><surname>Perez</surname><given-names>E.</given-names></name>
<name><surname>Frankena</surname><given-names>K.</given-names></name>
</person-group><article-title>Effect of a killed whole <italic toggle="yes">Neospora caninum</italic> tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions</article-title><source>Vet. Parasitol.</source><year>2004</year><volume>123</volume><fpage>149</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2004.06.016</pub-id><pub-id pub-id-type="pmid">15325041</pub-id>
</element-citation></ref><ref id="B23-vaccines-13-00131"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weston</surname><given-names>J.F.</given-names></name>
<name><surname>Heuer</surname><given-names>C.</given-names></name>
<name><surname>Williamson</surname><given-names>N.B.</given-names></name>
</person-group><article-title>Efficacy of a <italic toggle="yes">Neospora caninum</italic> killed tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle</article-title><source>Prev. Vet. Med.</source><year>2012</year><volume>103</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.prevetmed.2011.08.010</pub-id><pub-id pub-id-type="pmid">21925752</pub-id>
</element-citation></ref><ref id="B24-vaccines-13-00131"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fish</surname><given-names>L.</given-names></name>
<name><surname>Mazuz</surname><given-names>M.</given-names></name>
<name><surname>Molad</surname><given-names>T.</given-names></name>
<name><surname>Savitsky</surname><given-names>I.</given-names></name>
<name><surname>Shkap</surname><given-names>V.</given-names></name>
</person-group><article-title>Isolation of <italic toggle="yes">Neospora caninum</italic> from dairy zero grazing cattle in Israel</article-title><source>Vet. Parasitol.</source><year>2007</year><volume>149</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2007.08.009</pub-id><pub-id pub-id-type="pmid">17850972</pub-id>
</element-citation></ref><ref id="B25-vaccines-13-00131"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mazuz</surname><given-names>M.L.</given-names></name>
<name><surname>Fish</surname><given-names>L.</given-names></name>
<name><surname>Wolkomirsky</surname><given-names>R.</given-names></name>
<name><surname>Leibovich</surname><given-names>B.</given-names></name>
<name><surname>Reznikov</surname><given-names>D.</given-names></name>
<name><surname>Savitsky</surname><given-names>I.</given-names></name>
<name><surname>Golenser</surname><given-names>J.</given-names></name>
<name><surname>Shkap</surname><given-names>V.</given-names></name>
</person-group><article-title>The effect of a live <italic toggle="yes">Neospora caninum</italic> tachyzoite vaccine in naturally infected pregnant dairy cows</article-title><source>Prev. Vet. Med.</source><year>2015</year><volume>120</volume><fpage>232</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.prevetmed.2015.03.020</pub-id><pub-id pub-id-type="pmid">25890821</pub-id>
</element-citation></ref><ref id="B26-vaccines-13-00131"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopez</surname><given-names>A.J.</given-names></name>
<name><surname>Heinrichs</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Invited review: The importance of colostrum in the newborn dairy calf</article-title><source>J. Dairy Sci.</source><year>2022</year><volume>105</volume><fpage>2733</fpage><lpage>2749</lpage><pub-id pub-id-type="doi">10.3168/jds.2020-20114</pub-id><pub-id pub-id-type="pmid">35094859</pub-id>
</element-citation></ref><ref id="B27-vaccines-13-00131"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shkap</surname><given-names>V.</given-names></name>
<name><surname>Reske</surname><given-names>A.</given-names></name>
<name><surname>Pipano</surname><given-names>E.</given-names></name>
<name><surname>Fish</surname><given-names>L.</given-names></name>
<name><surname>Baszler</surname><given-names>T.</given-names></name>
</person-group><article-title>Immunological relationship between <italic toggle="yes">Neospora caninum</italic> and <italic toggle="yes">Besnoitia besnoiti</italic></article-title><source>Vet. Parasitol.</source><year>2002</year><volume>106</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/S0304-4017(02)00030-4</pub-id><pub-id pub-id-type="pmid">11992709</pub-id>
</element-citation></ref><ref id="B28-vaccines-13-00131"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stenlund</surname><given-names>S.</given-names></name>
<name><surname>Kindahl</surname><given-names>H.</given-names></name>
<name><surname>Magnusson</surname><given-names>U.</given-names></name>
<name><surname>Uggla</surname><given-names>A.</given-names></name>
<name><surname>Bjorkman</surname><given-names>C.</given-names></name>
</person-group><article-title>Serum antibody profile and reproductive performance during two consecutive pregnancies of cows naturally infected with <italic toggle="yes">Neospora caninum</italic></article-title><source>Vet. Parasitol.</source><year>1999</year><volume>85</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/S0304-4017(99)00120-X</pub-id><pub-id pub-id-type="pmid">10488725</pub-id>
</element-citation></ref><ref id="B29-vaccines-13-00131"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>More</surname><given-names>G.</given-names></name>
<name><surname>Bacigalupe</surname><given-names>D.</given-names></name>
<name><surname>Basso</surname><given-names>W.</given-names></name>
<name><surname>Rambeaud</surname><given-names>M.</given-names></name>
<name><surname>Beltrame</surname><given-names>F.</given-names></name>
<name><surname>Ramirez</surname><given-names>B.</given-names></name>
<name><surname>Venturini</surname><given-names>M.C.</given-names></name>
<name><surname>Venturini</surname><given-names>L.</given-names></name>
</person-group><article-title>Frequency of horizontal and vertical transmission for Sarcocystis cruzi and <italic toggle="yes">Neospora caninum</italic> in dairy cattle</article-title><source>Vet. Parasitol.</source><year>2009</year><volume>160</volume><fpage>51</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2008.10.081</pub-id><pub-id pub-id-type="pmid">19070964</pub-id>
</element-citation></ref><ref id="B30-vaccines-13-00131"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davison</surname><given-names>H.C.</given-names></name>
<name><surname>Otter</surname><given-names>A.</given-names></name>
<name><surname>Trees</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Estimation of vertical and horizontal transmission parameters of <italic toggle="yes">Neospora caninum</italic> infections in dairy cattle</article-title><source>Int. J. Parasitol.</source><year>1999</year><volume>29</volume><fpage>1683</fpage><lpage>1689</lpage><pub-id pub-id-type="doi">10.1016/S0020-7519(99)00129-0</pub-id><pub-id pub-id-type="pmid">10608455</pub-id>
</element-citation></ref><ref id="B31-vaccines-13-00131"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>D.J.</given-names></name>
<name><surname>Guy</surname><given-names>C.S.</given-names></name>
<name><surname>McGarry</surname><given-names>J.W.</given-names></name>
<name><surname>Guy</surname><given-names>F.</given-names></name>
<name><surname>Tasker</surname><given-names>L.</given-names></name>
<name><surname>Smith</surname><given-names>R.F.</given-names></name>
<name><surname>MacEachern</surname><given-names>K.</given-names></name>
<name><surname>Cripps</surname><given-names>P.J.</given-names></name>
<name><surname>Kelly</surname><given-names>D.F.</given-names></name>
<name><surname>Trees</surname><given-names>A.J.</given-names></name>
</person-group><article-title><italic toggle="yes">Neospora caninum</italic>-associated abortion in cattle: The time of experimentally-induced parasitaemia during gestation determines foetal survival</article-title><source>Parasitology</source><year>2000</year><volume>121</volume><issue-part>Pt 4</issue-part><fpage>347</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1017/S0031182099006587</pub-id><pub-id pub-id-type="pmid">11072897</pub-id>
</element-citation></ref><ref id="B32-vaccines-13-00131"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Barros</surname><given-names>L.D.</given-names></name>
<name><surname>Bogado</surname><given-names>A.L.G.</given-names></name>
<name><surname>Furlan</surname><given-names>D.</given-names></name>
<name><surname>de Melo Jardim</surname><given-names>A.</given-names></name>
<name><surname>Okano</surname><given-names>W.</given-names></name>
<name><surname>da Silva</surname><given-names>L.C.</given-names></name>
<name><surname>Pereira</surname><given-names>C.E.S.</given-names></name>
<name><surname>Bronkhorst</surname><given-names>D.E.</given-names></name>
<name><surname>Cardim</surname><given-names>S.T.</given-names></name>
<name><surname>Garcia</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Effects of <italic toggle="yes">Neospora caninum</italic> on reproductive parameters in dairy cows from a closed herd in Brazil</article-title><source>Vet. Parasitol. Reg. Stud. Rep.</source><year>2021</year><volume>23</volume><fpage>100524</fpage><pub-id pub-id-type="doi">10.1016/j.vprsr.2020.100524</pub-id></element-citation></ref><ref id="B33-vaccines-13-00131"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reichel</surname><given-names>M.P.</given-names></name>
<name><surname>Wahl</surname><given-names>L.C.</given-names></name>
<name><surname>Ellis</surname><given-names>J.T.</given-names></name>
</person-group><article-title>Research into <italic toggle="yes">Neospora caninum</italic>&#x02014;What have we learnt in the last thirty years?</article-title><source>Pathogens</source><year>2020</year><volume>9</volume><elocation-id>505</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens9060505</pub-id><pub-id pub-id-type="pmid">32585955</pub-id>
</element-citation></ref><ref id="B34-vaccines-13-00131"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marugan-Hernandez</surname><given-names>V.</given-names></name>
</person-group><article-title><italic toggle="yes">Neospora caninum</italic> and Bovine Neosporosis: Current Vaccine Research</article-title><source>J. Comp. Pathol.</source><year>2017</year><volume>157</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/j.jcpa.2017.08.001</pub-id><pub-id pub-id-type="pmid">28942304</pub-id>
</element-citation></ref><ref id="B35-vaccines-13-00131"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pipano</surname><given-names>E.</given-names></name>
</person-group><article-title>Vaccines against hemoparasitic diseases in Israel with special reference to quality assurance</article-title><source>Trop. Anim. Health Prod.</source><year>1997</year><volume>29</volume><fpage>86S</fpage><lpage>90S</lpage><pub-id pub-id-type="doi">10.1007/BF02632940</pub-id><pub-id pub-id-type="pmid">9512751</pub-id>
</element-citation></ref><ref id="B36-vaccines-13-00131"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bjorkman</surname><given-names>C.</given-names></name>
<name><surname>Alenius</surname><given-names>S.</given-names></name>
<name><surname>Manuelsson</surname><given-names>U.</given-names></name>
<name><surname>Uggla</surname><given-names>A.</given-names></name>
</person-group><article-title><italic toggle="yes">Neospora caninum</italic> and bovine virus diarrhoea virus infections in Swedish dairy cows in relation to abortion</article-title><source>Vet. J.</source><year>2000</year><volume>159</volume><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1053/tvjl.1999.0446</pub-id><pub-id pub-id-type="pmid">10712809</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vaccines-13-00131-f001"><label>Figure 1</label><caption><p>The study design, including the number of cows included in each group.</p></caption><graphic xlink:href="vaccines-13-00131-g001" position="float"/></fig><fig position="float" id="vaccines-13-00131-f002"><label>Figure 2</label><caption><p>The distribution of antibody titers in 1059 heifers sampled on days 110&#x02013;120 of their first pregnancy.</p></caption><graphic xlink:href="vaccines-13-00131-g002" position="float"/></fig><table-wrap position="float" id="vaccines-13-00131-t001"><object-id pub-id-type="pii">vaccines-13-00131-t001_Table 1</object-id><label>Table 1</label><caption><p><italic toggle="yes">Neospora</italic> seroprevalence in heifers sampled on days 110&#x02013;120 of their first pregnancy in the five farms included in this study, and the number of vaccinated heifers at each farm.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Farm</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Negative</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Borderline (1:200)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Positive (&#x02265;1:800)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccinated</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Farm 1</td><td align="left" valign="middle" rowspan="1" colspan="1">22 (17.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">37 (28.7%)</td><td align="left" valign="middle" rowspan="1" colspan="1">70 (54.3%)</td><td align="left" valign="middle" rowspan="1" colspan="1">33</td><td align="left" valign="middle" rowspan="1" colspan="1">129</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Farm 2</td><td align="left" valign="middle" rowspan="1" colspan="1">70 (32.7%)</td><td align="left" valign="middle" rowspan="1" colspan="1">58 (27.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">86 (40.2%)</td><td align="left" valign="middle" rowspan="1" colspan="1">45</td><td align="left" valign="middle" rowspan="1" colspan="1">214</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Farm 3</td><td align="left" valign="middle" rowspan="1" colspan="1">32 (21.3%)</td><td align="left" valign="middle" rowspan="1" colspan="1">24 (16.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">94 (62.7%)</td><td align="left" valign="middle" rowspan="1" colspan="1">46</td><td align="left" valign="middle" rowspan="1" colspan="1">150</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Farm 5</td><td align="left" valign="middle" rowspan="1" colspan="1">231 (51.3%)</td><td align="left" valign="middle" rowspan="1" colspan="1">139 (30.9%)</td><td align="left" valign="middle" rowspan="1" colspan="1">80 (17.8%)</td><td align="left" valign="middle" rowspan="1" colspan="1">40</td><td align="left" valign="middle" rowspan="1" colspan="1">450</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Farm 6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 (51.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35 (30.2%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (18.1%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">116</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">415 (39.2%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">293 (27.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">351 (33.1%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">173</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1059</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-13-00131-t002"><object-id pub-id-type="pii">vaccines-13-00131-t002_Table 2</object-id><label>Table 2</label><caption><p><italic toggle="yes">Neospora</italic> serological titer in 198 unvaccinated cows sampled over two consecutive pregnancies, measured on days 110&#x02013;120 of the first pregnancy of the heifers (rows), and again during their following pregnancy (columns).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"/><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"/><th colspan="2" align="left" valign="middle" style="border-top:solid thin" rowspan="1">Second Pregnancy</th><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"/><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"/></tr><tr><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1:200</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;1:800</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>First pregnancy</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">53</td><td align="left" valign="middle" rowspan="1" colspan="1">26</td><td align="left" valign="middle" rowspan="1" colspan="1">4</td><td align="left" valign="middle" rowspan="1" colspan="1">83</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1:200</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">36</td><td align="left" valign="middle" rowspan="1" colspan="1">16</td><td align="left" valign="middle" rowspan="1" colspan="1">9</td><td align="left" valign="middle" rowspan="1" colspan="1">61</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02265;1:800</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">8</td><td align="left" valign="middle" rowspan="1" colspan="1">9</td><td align="left" valign="middle" rowspan="1" colspan="1">37</td><td align="left" valign="middle" rowspan="1" colspan="1">54</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">198</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-13-00131-t003"><object-id pub-id-type="pii">vaccines-13-00131-t003_Table 3</object-id><label>Table 3</label><caption><p><italic toggle="yes">Neospora</italic> antibody titer in 11 unvaccinated cows sampled on days 110&#x02013;120 over three consecutive pregnancies. The intensity of the background color reflects the serological status (negative, borderline or high antibody titer).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"/><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Pregnancy</th><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"/><th align="left" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"/></tr><tr><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cow No.</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">2761</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2781</td><td align="left" valign="middle" style="background:#E7E6E6" rowspan="1" colspan="1">200</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2798</td><td align="left" valign="middle" style="background:#E7E6E6" rowspan="1" colspan="1">200</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2802</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td><td align="left" valign="middle" style="background:#E7E6E6" rowspan="1" colspan="1">200</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2852</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td><td align="left" valign="middle" style="background:#E7E6E6" rowspan="1" colspan="1">200</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2882</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2900</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">7231</td><td align="left" valign="middle" style="background:#E7E6E6" rowspan="1" colspan="1">200</td><td align="left" valign="middle" style="background:#E7E6E6" rowspan="1" colspan="1">200</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">7255</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">800</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">7270</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td><td align="left" valign="middle" style="background:#E7E6E6" rowspan="1" colspan="1">200</td><td align="left" valign="middle" style="background:#BFBFBF" rowspan="1" colspan="1">3200</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7305</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">800</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">800</td><td align="left" valign="middle" style="border-bottom:solid thin;background:#BFBFBF" rowspan="1" colspan="1">800</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-13-00131-t004"><object-id pub-id-type="pii">vaccines-13-00131-t004_Table 4</object-id><label>Table 4</label><caption><p>Vertical transmission of neosporosis from dams to their calves. The association between the serological status between dams and their newborn calves prior to the ingestion of colostrum is described.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Dam Serological Status</th><th colspan="8" align="left" valign="middle" style="border-top:solid thin" rowspan="1">Calf Serological Status</th></tr><tr><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1:200</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1:800</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1:3200</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1:12,800</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive &#x02265;1:200 (%)</th><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive &#x02265;1:800 (%)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">30</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">31</td><td align="left" valign="middle" rowspan="1" colspan="1">3.2</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1:200</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">27</td><td align="left" valign="middle" rowspan="1" colspan="1">6</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1">5</td><td align="left" valign="middle" rowspan="1" colspan="1">4</td><td align="left" valign="middle" rowspan="1" colspan="1">43</td><td align="left" valign="middle" rowspan="1" colspan="1">37.2</td><td align="left" valign="middle" rowspan="1" colspan="1">23.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1:800</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">5</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">4</td><td align="left" valign="middle" rowspan="1" colspan="1">12</td><td align="left" valign="middle" rowspan="1" colspan="1">11</td><td align="left" valign="middle" rowspan="1" colspan="1">34 *</td><td align="left" valign="middle" rowspan="1" colspan="1">85.3</td><td align="left" valign="middle" rowspan="1" colspan="1">79.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1:3200</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">3</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">12</td><td align="left" valign="middle" rowspan="1" colspan="1">7</td><td align="left" valign="middle" rowspan="1" colspan="1">25 **</td><td align="left" valign="middle" rowspan="1" colspan="1">88.0</td><td align="left" valign="middle" rowspan="1" colspan="1">84.0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1:12,800</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">0</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1">3 ***</td><td align="left" valign="middle" rowspan="1" colspan="1">100</td><td align="left" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">136</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.8</td></tr></tbody></table><table-wrap-foot><fn><p>As no significant differences were observed in the vertical transmission of vaccinated and unvaccinated dams, this Table includesall tested calves, of which * 15/34, ** 11/25 or *** 3/3 were of vaccinated dams.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-13-00131-t005"><object-id pub-id-type="pii">vaccines-13-00131-t005_Table 5</object-id><label>Table 5</label><caption><p>The number of inseminations required to achieve pregnancy in the first four pregnancies of 1059 cows in five farms during the study period. Comparisons between the rates of multiple inseminations (&#x02265;3) in each pregnancy are presented as odds ratios (ORs) with 95% confidence intervals (95% CIs), and their statistical significance (Fisher&#x02019;s exact).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pregnancy</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;2</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;3</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR (95% CI)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">658</td><td align="left" valign="middle" rowspan="1" colspan="1">380 (36.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">1038</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td><td align="left" valign="middle" rowspan="1" colspan="1">Ref</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>2</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">419</td><td align="left" valign="middle" rowspan="1" colspan="1">425 (50.4%)</td><td align="left" valign="middle" rowspan="1" colspan="1">844</td><td align="left" valign="middle" rowspan="1" colspan="1">1.76 (1.46&#x02013;2.12)</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">82</td><td align="left" valign="middle" rowspan="1" colspan="1">55 (40.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">137</td><td align="left" valign="middle" rowspan="1" colspan="1">1.16 (0.81&#x02013;1.67)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.421</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (40.0%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.87 (0.08&#x02013;9.58)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.906</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1162</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">862 (42.6%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2024</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-13-00131-t006"><object-id pub-id-type="pii">vaccines-13-00131-t006_Table 6</object-id><label>Table 6</label><caption><p>The outcome of 1475 pregnancies of 1059 cows in five farms during the study period. A comparison between abortion rates according to the number of pregnancies is presented as odds ratios (ORs) with 95% confidence intervals (95% CIs), and their statistical significance (Fisher&#x02019;s exact).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pregnancy</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Calving</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Abortion</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR (95% CI)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">924</td><td align="left" valign="middle" rowspan="1" colspan="1">82 (8.5%)</td><td align="left" valign="middle" rowspan="1" colspan="1">1006</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>2</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">364</td><td align="left" valign="middle" rowspan="1" colspan="1">79 (17.8%)</td><td align="left" valign="middle" rowspan="1" colspan="1">443</td><td align="left" valign="middle" rowspan="1" colspan="1">2.45 (1.75&#x02013;3.41)</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (46.2%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.66 (4.32&#x02013;21.57)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1302</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">173 (11.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1475</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-13-00131-t007"><object-id pub-id-type="pii">vaccines-13-00131-t007_Table 7</object-id><label>Table 7</label><caption><p>The rate of abortions, multiple inseminations (three or more) and removal from the herd in 1238 bovine pregnancies according to their <italic toggle="yes">Neospora</italic> serological status and vaccine status during pregnancy. The statistical significance of the difference between serological groups and between vaccinated and unvaccinated cows with high serological titers (1:800 or higher) was evaluated using Fisher&#x02019;s exact test and is presented for each parameter along with the OR and 95% CI, when relevant.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antibody<break/>Titer</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Abortions</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR<break/>(95% CI)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Multiple Inseminations</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Removed from Herd</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR<break/>(95% CI)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Removed Due to Reduced Fertility</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>0</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">483</td><td align="left" valign="middle" rowspan="1" colspan="1">15 (3.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">Ref</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td><td align="left" valign="middle" rowspan="1" colspan="1">201 (41.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td><td align="left" valign="middle" rowspan="1" colspan="1">24 (5.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td><td align="left" valign="middle" rowspan="1" colspan="1">6/24 (25.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>1:200</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">335</td><td align="left" valign="middle" rowspan="1" colspan="1">25 (7.5%)</td><td align="left" valign="middle" rowspan="1" colspan="1">2.52<break/>(1.31&#x02013;4.85)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.006</td><td align="left" valign="middle" rowspan="1" colspan="1">139 (41.5%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.972</td><td align="left" valign="middle" rowspan="1" colspan="1">33 (9.9%)</td><td align="left" valign="middle" rowspan="1" colspan="1">2.09<break/>(1.21&#x02013;3.61)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.008</td><td align="left" valign="middle" rowspan="1" colspan="1">4/33 (12.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.215</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&#x02265;1:800</bold>
<break/>
<bold>Un-Vac</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">227</td><td align="left" valign="middle" rowspan="1" colspan="1">42 (18.5%)</td><td align="left" valign="middle" rowspan="1" colspan="1">7.08<break/>(3.84&#x02013;13.08)</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" valign="middle" rowspan="1" colspan="1">89 (39.4%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.573</td><td align="left" valign="middle" rowspan="1" colspan="1">27 (11.9%)</td><td align="left" valign="middle" rowspan="1" colspan="1">2.58<break/>(1.45&#x02013;4.58)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.001</td><td align="left" valign="middle" rowspan="1" colspan="1">14/27 (51.9%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.054</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>&#x02265;1:800</bold>
<break/>
<bold>Vac</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">193</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 (16.6%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88<break/>(0.53&#x02013;1.45)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.607 *</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73 (37.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.744</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (8.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72 *<break/>(0.37&#x02013;1.36)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.305 *</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10/17 (58.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.651 *</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1238</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">114 (9.2%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">502 (40.6%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">101 (8.2%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34/101 (33.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>* Compared with &#x02265;1:800 unvaccinated dams.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-13-00131-t008"><object-id pub-id-type="pii">vaccines-13-00131-t008_Table 8</object-id><label>Table 8</label><caption><p>The rates of cows seropositive for neosporosis at an IFAT titer of 1:200, abortions, multiple inseminations (three or more) and removal from the herd in 1045 bovine pregnancies in the five dairy farms that participated in this study. The significance of the difference between farms using the univariable GEE test, with the cow defined as within subject effect, appears at the bottom of each column. Multiple comparisons between the farms are presented for parameters with significant associations, along with their significance through their OR and 95% CI.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Farm</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Seropositive or Borderline Titer (1:200)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR<break/>(95% CI)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Abortions</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR<break/>(95% CI)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Multiple Inseminations</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Removed from Herd</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Removed Due to Reduced Fertility</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 1</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">126</td><td align="left" valign="middle" rowspan="1" colspan="1">97 (77.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">4.20<break/>(2.39&#x02013;7.39)</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" valign="middle" rowspan="1" colspan="1">25 (19.8%)</td><td align="left" valign="middle" rowspan="1" colspan="1">3.5<break/>(1.45&#x02013;8.46)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.005</td><td align="left" valign="middle" rowspan="1" colspan="1">62 (49.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">14 (11.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">2/14 (14.3%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 2</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">244</td><td align="left" valign="middle" rowspan="1" colspan="1">140 (57.4%)</td><td align="left" valign="middle" rowspan="1" colspan="1">1.69<break/>(1.07&#x02013;2.68)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.025</td><td align="left" valign="middle" rowspan="1" colspan="1">16 (6.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.99<break/>(0.39&#x02013;2.45)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.987</td><td align="left" valign="middle" rowspan="1" colspan="1">89 (36.5%)</td><td align="left" valign="middle" rowspan="1" colspan="1">16 (6.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">7/16 (43.8%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 3</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">119</td><td align="left" valign="middle" rowspan="1" colspan="1">85 (71.4%)</td><td align="left" valign="middle" rowspan="1" colspan="1">3.14<break/>(1.81&#x02013;5.45)</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" valign="middle" rowspan="1" colspan="1">15 (12.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">2.1<break/>(0.79&#x02013;5.21)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.137</td><td align="left" valign="middle" rowspan="1" colspan="1">50 (42.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">9 (7.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">5/9 (55.6%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 5</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">450</td><td align="left" valign="middle" rowspan="1" colspan="1">193 (42.9%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.94<break/>(0.62&#x02013;1.44)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.786</td><td align="left" valign="middle" rowspan="1" colspan="1">19 (4.2%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.62<break/>(0.25&#x02013;1.52)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.300</td><td align="left" valign="middle" rowspan="1" colspan="1">186 (41.3%)</td><td align="left" valign="middle" rowspan="1" colspan="1">39 (8.7%)</td><td align="left" valign="middle" rowspan="1" colspan="1">9/39 (23/1%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Farm 6</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">106</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47 (44.3%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ref</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (6.6%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ref</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42 (39.6%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (5.7%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/6 (16.7%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">1045</td><td align="left" valign="middle" rowspan="1" colspan="1">562 (53.8%)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">82 (7.8%)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">429 (41.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">84 (8.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">24/84 (28.6%)</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Sig</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.499</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.145</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-13-00131-t009"><object-id pub-id-type="pii">vaccines-13-00131-t009_Table 9</object-id><label>Table 9</label><caption><p>The rate of abortions in the five dairy farms that participated in this study in cows that were seropositive for neosporosis with a titer of at least 1:800 according to their vaccination status against neosporosis during pregnancy using live frozen vaccination. The statistical significance (chi-square test) of the association between vaccination status and abortion rate, along with the vaccine efficacy (VE), are specified for each farm.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Farm</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N<break/>Unvaccinated</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Abortions (%)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N Vaccinated</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Abortions<break/>(%)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">VE</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 1</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">49</td><td align="left" valign="middle" rowspan="1" colspan="1">14 (28.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">40</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (20.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.351</td><td align="left" valign="middle" rowspan="1" colspan="1">30%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 2</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">65</td><td align="left" valign="middle" rowspan="1" colspan="1">10 (15.4%)</td><td align="left" valign="middle" rowspan="1" colspan="1">56</td><td align="left" valign="middle" rowspan="1" colspan="1">4 (7.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.158</td><td align="left" valign="middle" rowspan="1" colspan="1">54%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 3</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">57</td><td align="left" valign="middle" rowspan="1" colspan="1">11 (19.3%)</td><td align="left" valign="middle" rowspan="1" colspan="1">46</td><td align="left" valign="middle" rowspan="1" colspan="1">12 (26.1%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.411</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;35%</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Farm 5</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">44</td><td align="left" valign="middle" rowspan="1" colspan="1">6 (13.6%)</td><td align="left" valign="middle" rowspan="1" colspan="1">42</td><td align="left" valign="middle" rowspan="1" colspan="1">6 (14.3%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.931</td><td align="left" valign="middle" rowspan="1" colspan="1">&#x02212;5%</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Farm 6</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (8.3%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (22.2%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.479</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;167%</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">227</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42 (18.5%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">193</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 (16.6%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.700</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.40%</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-13-00131-t010"><object-id pub-id-type="pii">vaccines-13-00131-t010_Table 10</object-id><label>Table 10</label><caption><p>The rate of abortions in cows that were sampled during at least two pregnancies and that were seropositive for neosporosis with a titer of at least 1:800 as heifers, according to the number of pregnancies during which they were vaccinated against neosporosis using live frozen vaccination.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"/><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Abortions (%)</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Unvaccinated</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">49</td><td align="left" valign="middle" rowspan="1" colspan="1">8 (16.3%)</td><td align="left" valign="middle" rowspan="1" colspan="1">ref</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Single vaccination</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">35</td><td align="left" valign="middle" rowspan="1" colspan="1">7 (20.0%)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.775</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Double vaccination</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (17.4%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">107</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 (17.8%)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></floats-group></article>